85Q logo

Trellus Health plcDB:85Q Stock Report

Market Cap €962.6k
Share Price
€0.004
My Fair Value
n/a
1Y700.0%
7D-11.1%
Portfolio Value
View

Trellus Health plc

DB:85Q Stock Report

Market Cap: €962.6k

Trellus Health (85Q) Stock Overview

Provides digital chronic condition management solutions for employers and health plans. More details

85Q fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

85Q Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Trellus Health plc Competitors

Price History & Performance

Summary of share price highs, lows and changes for Trellus Health
Historical stock prices
Current Share PriceUK£0.004
52 Week HighUK£0.056
52 Week LowUK£0.0005
Beta2.09
1 Month Change-46.67%
3 Month Change-38.46%
1 Year Change700.00%
3 Year Change-94.41%
5 Year Changen/a
Change since IPO-99.46%

Recent News & Updates

Recent updates

Shareholder Returns

85QDE HealthcareDE Market
7D-11.1%-3.0%-3.3%
1Y700.0%23.7%10.6%

Return vs Industry: 85Q exceeded the German Healthcare industry which returned 26.4% over the past year.

Return vs Market: 85Q exceeded the German Market which returned 12% over the past year.

Price Volatility

Is 85Q's price volatile compared to industry and market?
85Q volatility
85Q Average Weekly Movement196.6%
Healthcare Industry Average Movement6.5%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.9%
10% least volatile stocks in DE Market2.5%

Stable Share Price: 85Q's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 85Q's weekly volatility has decreased from 219% to 197% over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
202018Marla Dubinskywww.trellushealth.com

Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a proprietary HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease (IBD), including Crohn's Disease and ulcerative colitis.

Trellus Health plc Fundamentals Summary

How do Trellus Health's earnings and revenue compare to its market cap?
85Q fundamental statistics
Market cap€962.63k
Earnings (TTM)-€5.95m
Revenue (TTM)€310.03k
3.1x
P/S Ratio
-0.2x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
85Q income statement (TTM)
RevenueUS$359.00k
Cost of RevenueUS$0
Gross ProfitUS$359.00k
Other ExpensesUS$7.25m
Earnings-US$6.89m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.043
Gross Margin100.00%
Net Profit Margin-1,918.66%
Debt/Equity Ratio0%

How did 85Q perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/18 05:51
End of Day Share Price 2025/11/18 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Trellus Health plc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.